(Q54347306)

28 May 2018

title

TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA. (English)

1 reference

28 May 2018

1 reference

1 reference

3

1 reference

28 May 2018

Carl C Juhlin

4

1 reference

28 May 2018

author name string

Na Wang

1

1 reference

28 May 2018

Tiantian Liu

2

1 reference

28 May 2018

Jan Zedenius

5

1 reference

28 May 2018

Anders Höög

6

1 reference

28 May 2018

Catharina Larsson

7

1 reference

28 May 2018

Dawei Xu

8

1 reference

28 May 2018

language of work or name

English

0 references

publication date

4 June 2014

1 reference

28 May 2018

published in

Cancer

1 reference

28 May 2018

volume

120

1 reference

28 May 2018

issue

19

1 reference

28 May 2018

page(s)

2965-2979

1 reference

28 May 2018

Hallmarks of telomeres in ageing research

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Regulation of the human catalytic subunit of telomerase (hTERT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Human telomerase and its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Molecular regulation of telomerase activity in aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Telomerase and the endocrine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

TERT promoter mutations in familial and sporadic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Highly recurrent TERT promoter mutations in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Highly prevalent TERT promoter mutations in aggressive thyroid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Frequency of TERT promoter mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Comprehensive mutation analysis of the TERT promoter in bladder cancer and detection of mutations in voided urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

A PCR-based expression signature of malignancy in follicular thyroid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Do benign thyroid nodules have malignant potential? An evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Telomere measurement by quantitative PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Differential shortening rate of telomere length in the development of human fetus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Telomere attrition predominantly occurs in precursor lesions during in vivo carcinogenic process of the uterine cervix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

Telomerase expression predicts unfavorable outcome in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

7 January 2021

The WHO histological classification of thyroid tumors: a commentary on the second edition

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

7 January 2021

Specific pattern of RAS oncogene mutations in follicular thyroid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

7 January 2021

Thyroid nodular lesion: Analysis of cancer risk based on Kuma Hospital experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

7 January 2021

Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

7 January 2021

Immunodetection of human telomerase reverse-transcriptase (hTERT) re-appraised: nucleolin and telomerase cross paths

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28800

7 January 2021

Identifiers

DOI

10.1002/CNCR.28800

1 reference

28 May 2018

1 reference

28 May 2018